Acurx Pharmaceuticals, Inc. (ACXP) KPIs and segments

ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30

$0.96−0.03 (-2.54%)

Close on Nov 13, 2026Market cap $5.06MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Acurx Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to Acurx Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?